Estimated annual cost of asthma management totaled $2,181 per SMART-prescribed patient compared with $2,235 with traditional ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...
Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...
What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...
Written by Nicola MacDougall] Asthma is one of the most common chronic conditions affecting Bermudian children and adults, ...
Researchers and doctors are beginning to modernize asthma treatment using innovative therapies. Asthma is a common, chronic and treatable lung disease that touches nearly every family in America. It ...
Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...
U.S. Rep. Kweisi Mfume (D-Md.-7) and Sen. Angela Alsobrooks (D-Md.) are teaming up on a new push to provide relief to those suffering from chronic lung conditions. Both members of Congress have put ...
Respiratory specialists Dr Anna Haley and Dr Nita Sehgal discuss the key principles in management of asthma during pregnancy ...